Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 2
2013 2
2014 1
2016 2
2018 1
2019 1
2020 2
2021 7
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comes MC, Fanizzi A, Bove S, Didonna V, Diotiaiuti S, Fadda F, La Forgia D, Giotta F, Latorre A, Nardone A, Palmiotti G, Ressa CM, Rinaldi L, Rizzo A, Talienti T, Tamborra P, Zito A, Lorusso V, Massafra R. Comes MC, et al. Among authors: tamborra p. Comput Biol Med. 2024 Apr;172:108132. doi: 10.1016/j.compbiomed.2024.108132. Epub 2024 Mar 14. Comput Biol Med. 2024. PMID: 38508058 Free article.
Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.
Fanizzi A, Pomarico D, Rizzo A, Bove S, Comes MC, Didonna V, Giotta F, La Forgia D, Latorre A, Pastena MI, Petruzzellis N, Rinaldi L, Tamborra P, Zito A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: tamborra p. Sci Rep. 2023 May 26;13(1):8575. doi: 10.1038/s41598-023-35344-9. Sci Rep. 2023. PMID: 37237020 Free PMC article.
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence.
Massafra R, Fanizzi A, Amoroso N, Bove S, Comes MC, Pomarico D, Didonna V, Diotaiuti S, Galati L, Giotta F, La Forgia D, Latorre A, Lombardi A, Nardone A, Pastena MI, Ressa CM, Rinaldi L, Tamborra P, Zito A, Paradiso AV, Bellotti R, Lorusso V. Massafra R, et al. Among authors: tamborra p. Front Med (Lausanne). 2023 Feb 2;10:1116354. doi: 10.3389/fmed.2023.1116354. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817766 Free PMC article.
Corrigendum: Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer.
Fanizzi A, Scognamillo G, Nestola A, Bambace S, Bove S, Comes MC, Cristofaro C, Didonna V, Di Rito A, Errico A, Palermo L, Tamborra P, Troiano M, Parisi S, Villani R, Zito A, Lioce M, Massafra R. Fanizzi A, et al. Among authors: tamborra p. Front Med (Lausanne). 2022 Nov 22;9:1089705. doi: 10.3389/fmed.2022.1089705. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36482915 Free PMC article.
Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer.
Fanizzi A, Scognamillo G, Nestola A, Bambace S, Bove S, Comes MC, Cristofaro C, Didonna V, Di Rito A, Errico A, Palermo L, Tamborra P, Troiano M, Parisi S, Villani R, Zito A, Lioce M, Massafra R. Fanizzi A, et al. Among authors: tamborra p. Front Med (Lausanne). 2022 Sep 23;9:993395. doi: 10.3389/fmed.2022.993395. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36213659 Free PMC article.
A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
Massafra R, Comes MC, Bove S, Didonna V, Diotaiuti S, Giotta F, Latorre A, La Forgia D, Nardone A, Pomarico D, Ressa CM, Rizzo A, Tamborra P, Zito A, Lorusso V, Fanizzi A. Massafra R, et al. Among authors: tamborra p. PLoS One. 2022 Sep 19;17(9):e0274691. doi: 10.1371/journal.pone.0274691. eCollection 2022. PLoS One. 2022. PMID: 36121822 Free PMC article.
Robustness Evaluation of a Deep Learning Model on Sagittal and Axial Breast DCE-MRIs to Predict Pathological Complete Response to Neoadjuvant Chemotherapy.
Massafra R, Comes MC, Bove S, Didonna V, Gatta G, Giotta F, Fanizzi A, La Forgia D, Latorre A, Pastena MI, Pomarico D, Rinaldi L, Tamborra P, Zito A, Lorusso V, Paradiso AV. Massafra R, et al. Among authors: tamborra p. J Pers Med. 2022 Jun 10;12(6):953. doi: 10.3390/jpm12060953. J Pers Med. 2022. PMID: 35743737 Free PMC article.
An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.
Massafra R, Bove S, La Forgia D, Comes MC, Didonna V, Gatta G, Giotta F, Latorre A, Nardone A, Palmiotti G, Quaresmini D, Rinaldi L, Tamborra P, Zito A, Rizzo A, Fanizzi A, Lorusso V. Massafra R, et al. Among authors: tamborra p. Cancers (Basel). 2022 Apr 28;14(9):2215. doi: 10.3390/cancers14092215. Cancers (Basel). 2022. PMID: 35565344 Free PMC article.
A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients.
Bove S, Comes MC, Lorusso V, Cristofaro C, Didonna V, Gatta G, Giotta F, La Forgia D, Latorre A, Pastena MI, Petruzzellis N, Pomarico D, Rinaldi L, Tamborra P, Zito A, Fanizzi A, Massafra R. Bove S, et al. Among authors: tamborra p. Sci Rep. 2022 May 12;12(1):7914. doi: 10.1038/s41598-022-11876-4. Sci Rep. 2022. PMID: 35552476 Free PMC article.
A Multicentre Evaluation of Dosiomics Features Reproducibility, Stability and Sensitivity.
Placidi L, Gioscio E, Garibaldi C, Rancati T, Fanizzi A, Maestri D, Massafra R, Menghi E, Mirandola A, Reggiori G, Sghedoni R, Tamborra P, Comi S, Lenkowicz J, Boldrini L, Avanzo M. Placidi L, et al. Among authors: tamborra p. Cancers (Basel). 2021 Jul 30;13(15):3835. doi: 10.3390/cancers13153835. Cancers (Basel). 2021. PMID: 34359737 Free PMC article.
26 results